Blood screening market to reach USD 4.83 billion by 2029

Blood screening market size was valued at USD 2.44 billion in 2020 and is projected to reach USD 4.83 billion by 2029, growing at a CAGR of 7.9% from 2022 to 2029.

Blood screening market offers recent industry information and highlights various trends impacting the growth of the market. It also highlights key vendors, various analysis techniques, and drivers with a market forecast from 2022 to 2029. Also, Blood Screening market size, trade facts conversation, and market share evaluation help to understand the entire structure of the industry accordingly. In addition to that, it lists business outlook, revenue, and consumption of Blood Screening Market by country.

This research report provides a detailed analysis of the global Blood Screening market and highlights key trends in product segmentation, business creation, revenue and market share, recent advancements, and M&A activity. This research additionally investigates the strategy of the largest international companies with a focus on blood screening portfolios and capabilities, market entrance strategies, market positions, and regional footprints in order to better understand these organisations’ unique positions in a growing global blood screening industry.

Global blood screening market and competitive analysis
Know the state of the market now! Given the constantly shifting market dynamics, it is crucial for both new products and existing ones. The study enables marketers to keep up with current consumer trends and industry categories where they can experience a sharp decline in market share. Discover your true competitors in the market by conducting a market share analysis to determine your market position, percent market share, and segmented revenue.

Market overview
The increasing number of blood donations around the world is a driving factor.

The availability and need for sophisticated surgical treatments, such as cardiovascular and transplant surgery, trauma care, and therapy for cancer and blood illnesses, are increasing the need for donated blood. Every year, around 235 million major surgeries are conducted worldwide, with 63 million traumatic procedures, over 31 million cancer-related surgeries, and 10 million pregnancy difficulties. In problematic childbirths, blood transfusions are generally ordered to prepare for childhood congenital maternal blood abnormalities, acute anaemia, and trauma.

Leading Players: Grifols, Roche, Abbott Laboratories, Biomérieux, Bio-Rad Laboratories, Inc., Siemens Healthineers, Ortho Clinical Diagnostics, Inc., Thermo Fisher Scientific, Inc., Beckman Coulter, Becton, Dickinson and Company, and others.

Recent developments
Grifols, S.A. is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma-based products, a field in which it is the European leader and largest worldwide, the company also supplies devices, instruments, and reagents for clinical testing laboratories.

Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.

Global blood screening market segmentations
Blood screening market by technology, 2020-2029, (USD Million)

• Nucleic Acid Testing (Nat)
• Elisa
• Rapid Tests
• Western Blot Assay
• Next-generation sequencing (Nsg)

Blood screening market by product, 2020-2029, (USD Million)

• Reagents & kits
• Instruments
• Software & services
• Blood screening market by end user, 2020-2029, (USD Million)
• Blood banks
• Hospitals

The segmentation chapter allows readers to comprehend facets of the global market for Blood Screening including its goods and services, available technologies, and applications. These chapters are written in such a way as to outline years of development as well as the process that will occur over the following several years. The research report also offers insightful details on recent trends that will probably determine how these market segments develop over the coming few years.

The downstream consumption typically follows established economies with strong economic growth, such as the BRICS, therefore companies in developed economies now prefer to invest in less developed countries.

According to the Regional Segmentation, the Blood Screening Market provides the Information covers following regions:
Here are some key aspects of the regional outlook:
Market Size and Growth: North America represents a sizable market with a large consumer base and significant purchasing power. The region offers diverse opportunities across various sectors, including technology, healthcare, automotive, retail, and financial services. The market is expected to witness steady growth, driven by innovation, digitalization, and evolving consumer preferences.

Emerging Markets: Emerging markets, particularly in Asia, Africa, and Latin America, present significant growth opportunities for market research. These regions are experiencing rapid economic development, urbanization, and changing consumer behaviors, creating a need for market research to understand local markets, consumer preferences, and emerging trends. Exactitude Consultancy